Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
182.08
+3.91 (2.19%)
At close: Jun 26, 2026, 4:00 PM EDT
182.85
+0.77 (0.42%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Revolution Medicines Employees
Revolution Medicines had 883 employees as of December 31, 2025. The number of employees increased by 349 or 65.36% compared to the previous year.
Employees
883
Change (1Y)
349
Growth (1Y)
65.36%
Revenue / Employee
n/a
Profits / Employee
-$1,553,455
Market Cap
38.71B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
RVMD News
- 3 days ago - Revolution Medicines to Present Clinical Data from RAS(ON) Inhibitor Combination Trials in Pancreatic Cancer at ESMO Gastrointestinal Cancers Congress 2026 - GlobeNewsWire
- 4 days ago - Revolution Medicines begins treating patients in RASolute 305 trial - TheFly
- 6 days ago - Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D. - GlobeNewsWire
- 20 days ago - RBC Capital says Tango-Revolution data strengthens daraxonrasib’s PDAC position - TheFly
- 20 days ago - Tango Therapeutics announces data from study of vopimetostat, daraxonrasib - TheFly
- 26 days ago - Revolution Medicines price target raised to $182 from $165 at RBC Capital - TheFly
- 26 days ago - Wedbush reiterates Outperform on Revolution Medicines after ASCO data - TheFly
- 26 days ago - Revolution Medicines price target raised to $195 from $169 at H.C. Wainwright - TheFly